Steve Mandel acquired 11.8M Medline shares worth $485M. That's 2.98% of their equity portfolio (15th largest holding). The investor owns 1.44% of the outstanding Medline stock. The investor's estimated purchase price is $505M, resulting in a loss of 4.1%.